Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TUBD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MRPL47 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNAL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506248 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HJURP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DHFR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP83 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR3654 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAP1GDS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OTUD6B-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELOVL2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAGR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAGLN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NBPF20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on